Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Safety and Efficacy of DSM 32444 Postbiotic in the Treatment of Acute Rhinosinusitis
Not Applicable
Completed
- Conditions
- RhinosinusitisRhinitis
- Interventions
- Combination Product: Bacillus subtilis DSM32444Drug: Neomycin/ Dexameythasone/Xylometazoline
- First Posted Date
- 2023-08-21
- Last Posted Date
- 2024-03-05
- Lead Sponsor
- Huro Biotech Joint Stock Company
- Target Recruit Count
- 60
- Registration Number
- NCT05999955
- Locations
- 🇻🇳
Thai Binh University of Medicine and Pharmacy, Thái Bình, Thai Binh, Vietnam
Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans
Not Applicable
Completed
- Conditions
- Rhino Sinusitis
- Interventions
- Drug: 0.9% NaCl isotonic saline solutionCombination Product: Bacillus subtilis DSM32444, inactivated
- First Posted Date
- 2023-08-09
- Last Posted Date
- 2024-04-12
- Lead Sponsor
- Huro Biotech Joint Stock Company
- Target Recruit Count
- 60
- Registration Number
- NCT05984004
- Locations
- 🇻🇳
Thai Binh University of Medicine and Pharmacy, Thái Bình, Thai Binh, Vietnam
News
No news found